08622.HK
Huakang Biomedical Holdings Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.18
+0.00%Margins
Gross margin
62.4%
EBITDA margin
-14.1%
EBIT margin
-23.9%
Net margin
-16.0%
FCF margin
-8.5%
-12.5%
Return on equity
-9.3%
Return on assets
-16.2%
Return on invested capital
0.58x
Asset turnover
-HKD 2.6M
Cash from operations
HKD 0.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026